Emerging Concepts for the Treatment of Biofilm-Associated Bone and Joint Infections with IV Fosfomycin: A Literature Review
Due to the involvement of biofilms in the pathogenesis of bone and joint infections (BJI), the treatment of these infections is often challenging, especially when multidrug- or extensively drug-resistant (MDR/XDR) pathogens are involved. Intravenous fosfomycin (FOS) is a phosphoenolpyruvate analogue...
Saved in:
| Main Authors: | Sara Tedeschi, Efthymia Giannitsioti, Christian Mayer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/13/5/963 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study
by: Klaus-Friedrich Bodmann, et al.
Published: (2025-03-01) -
Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01) -
A Decade-Long Review of the Virulence, Resistance, and Epidemiological Risks of <i>Klebsiella pneumoniae</i> in ICUs
by: Tao-An Chen, et al.
Published: (2024-12-01) -
Ertapenem+meropenem including double carbapenem therapy (EMDCT) versus meropenem+imipenem including double carbapenem therapy (MIDCT) in the therapy of carbapenem-resistant Klebsiella pneumoniae infections (CRKPI): A retrospective matched cohort stud
by: Merve Mert Vahabi, et al.
Published: (2024-12-01) -
Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infections in a High-Endemic Hospital
by: Teresa López-Viñau, et al.
Published: (2024-08-01)